Linomide improves the effect of interstitial laser thermotherapy in a rat liver tumour model

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1257-1263

  Ivarsson, Kjell ^a   Sturesson, Christian ^a   Stenram, Unne ^a   Tranberg, Karl Göran ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Laser; Linomide; Macrophages; Thermotherapy; Tumour

Indexed keywords

ROQUINIMEX; VON WILLEBRAND FACTOR;

ADENOCARCINOMA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERTHERMIC THERAPY; LIVER TUMOR; LOW LEVEL LASER THERAPY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DRUG SCREENING ASSAYS, ANTITUMOR; HYDROXYQUINOLINES; HYPERTHERMIA, INDUCED; LASERS; LIVER NEOPLASMS, EXPERIMENTAL; MACROPHAGES; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 0037562854     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kalland T, Aim G and Stålhandske T: Augmentation of mouse natural killer activity by LS-2616, a new immunomodulator. J Immunol 134: 3956-3961, 1985.
2. Kalland T: Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma. Cancer Res 46: 3018-3022, 1986.
3. Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B and Isaacs JT: Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res 53: 1833-1837, 1993.
4. Vukanovic J and Isaacs JT: Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res 55: 1499-1504, 1995.
5. Steger AC, Lees WR, Walmsley K and Bown SG: Interstitial laser hyperthermia: a new approach to local destruction of tumours. Br Med J 299: 362-365, 1989.
6. Tranberg KG, Möller PH, Hannesson P and Stenram U: Interstitial laser treatment of malignant tumours: Initial experience. Eur J Surg Oncol 22: 47-54, 1996.
7. Möller PH, Ivarsson K, Stenram U, Radnell M and Tranberg K-G: Comparison between interstitial laser thermotherapy and excision of an adenocarcinoma transplanted into rat liver. Br J Cancer 77: 1884-1892, 1998.
8. Sturesson C, Ivarsson K, Stenram U, Andersson-Engels S and Tranberg K-G: Interstitial laser-induced thermotherapy of a rat liver tumour: effect of temperature and hepatic inflow occlusion. Submitted.
9. Steele GJ and Sjögren HO: Cross-reacting tumor-associated antigen(s) among chemically induced rat colon carcinomas. Cancer Res 34: 1801-1807, 1974.
10. Möller PH, Lindberg L, Henriksson PH, Persson BRR and Tranberg K-G: Temperature control and light penetration in a feedback interstitial laser thermotherapy system. Int J Hyperthermia 12: 49-63, 1996.
11. Möller PH, Ivarsson K, Stenram U, Radnell M and Tranberg K-G: Interstitial laser thermotherapy of an adenocarcinoma transplanted into rat liver. Eur J Surg 63: 867-870, 1997.
12. O'Reilly M, Holmgren L, Shing Y, Chen C, Rosenthal R, Moses M, Lane W, Cao Y, Sage H and Folman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
13. Dijkstra CD, Döpp EA, Joling P and Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54: 589-599, 1985.
14. Damoiseaux JGM, Döpp E.A, Calame W, Chao D, MacPherson GG and Dijkstra CD: Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83: 140-147, 1994.
15. Carlsson G, Gullberg B and Hafström L: Estimation of liver tumor volume using different formulas: an experimental study in rats. J Cancer Res Clin Oncol 105: 20-23, 1983.
16. Parenti A, Donnini S, Morbidelli L, Granger HJ and Ziche M: The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor. Br J Pharmacol 119: 619-621, 1996.
17. Nagler A, Feferman R and Shoshan S: Reduction in basic fibroblast growth factor mediated angiogenesis in vivo by Linomide. Connective Tissue Res 37: 61-68, 1998.
18. Joseph IBJK and Isaacs JT: The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis. Prostate 29: 183-190, 1996.
19. Xiao B-G, Bail X-F, Zhang G-X, Hedlund G and Link H: Linomide-mediated protection of oligodendrocytes is associated with inhibition of nitric oxide production and IL-1beta expression in Lewis rat glial cells. Neurosci Lett 249: 17-20, 1998.
20. Hortelano S, Diaz-Guerra MJ, Gonzalez-Garcia A, Leonardo E, Gamallo C, Bosca L and Martinez-A C: Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice. J Immunol 158: 1402-1408, 1997.
21. Ziche M, Donnini S, Morbidelli I, Parenti A, Gasparini G and Ledda F: Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants. Br J Cancer 77: 1123-1129, 1998.
22. Joseph IB and Isaacs JT: Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J Natl Cancer Inst 90: 1648-1653, 1998.